1. Home
  2. HOLX vs SNN Comparison

HOLX vs SNN Comparison

Compare HOLX & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hologic Inc.

HOLX

Hologic Inc.

HOLD

Current Price

$74.98

Market Cap

16.6B

Sector

Health Care

ML Signal

HOLD

Logo Smith & Nephew SNATS Inc.

SNN

Smith & Nephew SNATS Inc.

HOLD

Current Price

$33.44

Market Cap

14.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOLX
SNN
Founded
1985
1856
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Medical Electronics
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.6B
14.0B
IPO Year
1990
1999

Fundamental Metrics

Financial Performance
Metric
HOLX
SNN
Price
$74.98
$33.44
Analyst Decision
Hold
Hold
Analyst Count
15
4
Target Price
$79.64
$32.83
AVG Volume (30 Days)
3.0M
476.9K
Earning Date
11-03-2025
03-02-2026
Dividend Yield
N/A
2.19%
EPS Growth
N/A
59.91
EPS
2.49
0.56
Revenue
$4,100,500,000.00
$5,944,000,000.00
Revenue This Year
$6.69
$7.78
Revenue Next Year
$5.74
$5.13
P/E Ratio
$30.11
$29.10
Revenue Growth
1.74
5.35
52 Week Low
$51.90
$23.69
52 Week High
$80.31
$38.79

Technical Indicators

Market Signals
Indicator
HOLX
SNN
Relative Strength Index (RSI) 67.93 48.01
Support Level $74.55 $32.68
Resistance Level $75.12 $33.56
Average True Range (ATR) 0.28 0.41
MACD -0.14 0.14
Stochastic Oscillator 78.92 78.51

Price Performance

Historical Comparison
HOLX
SNN

About HOLX Hologic Inc.

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

About SNN Smith & Nephew SNATS Inc.

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Share on Social Networks: